ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
+51.92%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$259M
AUM Growth
+$51.7M
Cap. Flow
+$8.96M
Cap. Flow %
3.45%
Top 10 Hldgs %
66.68%
Holding
41
New
8
Increased
13
Reduced
5
Closed
12

Top Buys

1
AXSM icon
Axsome Therapeutics
AXSM
$11.3M
2
MIST icon
Milestone Pharmaceuticals
MIST
$9.42M
3
ATNX
Athenex, Inc. Common Stock
ATNX
$9.36M
4
ARWR icon
Arrowhead Research
ARWR
$8.24M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
$6.15M

Top Sells

1
CASM
CAS Medical Systems, Inc.
CASM
$12.8M
2
IOVA icon
Iovance Biotherapeutics
IOVA
$12.7M
3
DERM
Dermira, Inc.
DERM
$8.63M
4
ASMB icon
Assembly Biosciences
ASMB
$8.13M
5
CBAY
Cymabay Therapeutics
CBAY
$6.87M

Sector Composition

1 Healthcare 93.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CMRX
26
DELISTED
Chimerix, Inc.
CMRX
$1.21M 0.43%
+280,000
New +$1.21M
CEMI
27
DELISTED
Chembio diagnostics, Inc.
CEMI
$254K 0.09%
41,667
– –
ALEC icon
28
Alector
ALEC
$284M
– –
-200,000
Closed -$3.74M
ALLK
29
DELISTED
Allakos
ALLK
– –
-13,500
Closed -$547K
AMRN
30
Amarin Corp
AMRN
$310M
– –
-4,375
Closed -$1.82M
BCRX icon
31
BioCryst Pharmaceuticals
BCRX
$1.72B
– –
-25,000
Closed -$204K
ENTA icon
32
Enanta Pharmaceuticals
ENTA
$185M
– –
-61,000
Closed -$5.83M
GOSS icon
33
Gossamer Bio
GOSS
$618M
– –
-60,000
Closed -$1.3M
NVAX icon
34
Novavax
NVAX
$1.25B
– –
0
– –
STRO icon
35
Sutro Biopharma
STRO
$80.4M
– –
-45,500
Closed -$518K
XBI icon
36
SPDR S&P Biotech ETF
XBI
$5.33B
– –
0
– –
CBAY
37
DELISTED
Cymabay Therapeutics
CBAY
– –
-517,500
Closed -$6.87M
ACER
38
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
– –
-147,000
Closed -$3.57M
QTNT
39
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-7,000
Closed -$2.52M
DERM
40
DELISTED
Dermira, Inc.
DERM
– –
-636,500
Closed -$8.63M
CASM
41
DELISTED
CAS Medical Systems, Inc.
CASM
– –
-5,263,508
Closed -$12.8M
1
2